Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Haematologica|October 26, 2019
Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for <i>NPM-ALK</i> as a prognostic factor in children with anaplastic large cell lymphomaChristine Damm-Welk, Nina Kutscher, Martin Zimmermann, et al.
British Journal of Haematology|June 24, 2009
Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlationChristine Damm-Welk, Wolfram Klapper, Ilske Oschlies, et al.
Nanoscale|July 1, 2016
The surface-to-volume ratio: a key parameter in the thermoelectric transport of topological insulator Bi2Se3 nanowiresHo Sun Shin, Bacel Hamdou, Heiko Reith, et al.
Oncotarget|June 15, 2018
Characterization and diagnostic application of genomic <i>NPM-ALK</i> fusion sequences in anaplastic large-cell lymphomaManuela Krumbholz, Wilhelm Woessmann, Jakob Zierk, et al.
Physical Chemistry Chemical Physics : PCCP|January 11, 2014
The strong catalytic effect of Pb(II) on the oxygen reduction reaction on 5 nm gold nanoparticlesYing Wang, Eduardo Laborda, Blake J Plowman, et al.
Cancer Immunology Research|January 8, 2025
Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral BloodSerena Stadler, Rafael B Blasco, Vijay Kumar Singh, et al.
Journal of Materials Chemistry. B|April 9, 2020
A size dependent evaluation of the cytotoxicity and uptake of nanographene oxideRafael Gregorio Mendes, Britta Koch, Alicja Bachmatiuk, et al.
Blood|March 30, 2007
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphomaChristine Damm-Welk, Kerstin Busch, Birgit Burkhardt, et al.
Blood|December 4, 2013
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphomaChristine Damm-Welk, Lara Mussolin, Martin Zimmermann, et al.
Plos One|April 16, 2011
Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomasLeandro Cerchietti, Christine Damm-Welk, Inga Vater, et al.
Pageof 5